Plasma Levels of Ropivacaine and Bupivacaine during Postoperative Patient Controlled Thoracic Epiduralanalgesia;Plasmakonzentrationen von Ropivacain und Bupivacain während Postoperativer Patienten-Kontrollierter Thorakaler Epiduralanalgesie

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 38, Issue 11, 2003, Pages 705-709

  Gottschalk, André ^a   Burmeister, M A ^a   Freitag, M ^a   Bohme C ^a   Standl, T ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Local anesthetics: Bupivacaine, Ropivacaine; Plasma levels; Postoperative pain management; Thoracic epidural analgesia; Toxicity

Indexed keywords

BUPIVACAINE; ROPIVACAINE; SUFENTANIL;

ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG INFUSION; EPIDURAL CATHETER; HUMAN; HYPOTENSION; LOCAL ANESTHESIA; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYMPATHETIC BLOCKING; THORAX EPIDURAL ANESTHESIA;

ADULT; AGED; AMIDES; ANALGESIA, EPIDURAL; ANALGESIA, PATIENT-CONTROLLED; ANESTHETICS, LOCAL; BUPIVACAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; PAIN, POSTOPERATIVE; PROSPECTIVE STUDIES;

EID: 0344444866     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-43380     Document Type: Article

References (19)

1. Wiebalck A, Brodner G, van Aken H. The effects of adding sufentanil to bupivacaine for postoperative patient-controlled epidural analgesia. Anesth Analg 1997; 85: 124-129
2. Brodner G, Mertes N, van Aken H, Möllhoff T, Zahl M, Wirtz S, Marcus MAE, Buerkle H. What concentration of sufentanil should be combined with ropivacaine 0.2% wt/vol for postoperative patient controlled epidural analgesia? Anesth Analg 2000; 90 (3): 649-657
3. Adams HA, Biscoping J, Ludolf K, Borgmann A, Bachmann MB, Hempelmann G. Die quantitative Analyse von Amid-Lokalanaesthetika mittels Hochdruck-Flü ssigkeits-Chromatographie und UV-Detektion (HPLC/UV). Reg Anesth 1989; 12: 53-57
4. Burmeister MA, Gottschalk A, Wilhelm S, Schroeder F, Becker C, Standl T. Ropivacaine 0,2% versus Bupivacaine 0,125% plus Sufentanil zur kontinuierlichen Periduralanalgesie nach ausgedehnten abdominellen Operationen. Anästhesiol Intensivmed Notfallmed Schmerzther 2001; 36: 219-223
5. Gottschalk A, Freitag M, Burmeister MA, Becker C, Horn EP, Standl T. Patient controlled thoracic epidural infusion with ropivacaine 0.375% provides comparable pain relief as bupivacaine 0.125% plus sufentanil after major abdominal gynecologic tumor surgery. Reg Anesth Pain Med 2002; 27: 367-373
6. Knudsen K, Beckmann SuukülaM, Blomberg S, Sjowall J, Edwardsen N. Central nervous and cardiovascular effects of iv infusion of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 1997; 78: 507-514
7. Stamer U, Mpasios N, Stüber F, Laubenthal H, Maier C. Postoperative Schmerztherapie in Deutschland. Anaesthesist 2002; 51: 248-257
8. Stamer U, Mpasios N, Stüber F, Maier C. A survey of acute pain services in Germany and a discussion of international survey data. Reg Anesth Pain Med 2002; 27: 125-131
9. Rodgers A, Walker N, Schug S, Mc KeeA, Kehlet H, van Zundert A, Sage D, Futter M, Saville G, Clark T, MacMahon S. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomized trials. BMJ 2000; 321: 1493
10. Gruber EM, Tschernko EM, Kritzinger M, Deviatko E, Wisser W, Zarakowski D, Haider W. The effects of thoracic epidural analgesia with bupivacaine 0.25% on ventilatory mechanics in patients with severe chronic obstructive pulmonary disease. Anesth Analg 2001; 92: 1015-1019
11. Matot I, Oppenheim A, Ratrot R, Baranova J, Davidson E, Eylon S, Peyser A, Liebergall M. Preoperative cardiac events in eldery patients with hip fracture randomized to epidural or conventional analgesia. Anesthesiology 2003; 98: 156-163
12. Scott DA, Emanuelsson BM, Mooney PH, Cook RJ, Junestrand C. Pharmacokinetics and efficacy of long-term epidural ropivacaine infusion for postoperative analgesia. Anesth Analg 1997; 85: 1322-1330
13. Finucane BT, Sandler AN, McKenna J, Reid D, Milner AZ, Friedlander M, Mazyka D, O'Callahn-Enright S, Chon V. A double-blind comparison of ropivacaine 0.5%, 0.75%, 1.0% and bupivacaine 0.5%, injected epidurally, in patients undergoing abdominal hysterectomy. Can J Anaesth 1996; 43: 442-449
14. Scott DB, Lee A, Fagan D, Bowler GM, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69: 563-569
15. Pitkänen M, Feldmann HS, Authur GR, Covino BG. Chronotropic effects of ropivacaine, bupivacaine and lidocaine in the spontaneously beating and electrically paced isolated, perfused rabbit heart. Reg Anesth 1992; 17:183-192
16. Graf BM. The cardiotoxicity of local anesthetics: the place of ropivacaine. Curr Top Med Chem 2002; 1 (3): 207-214
17. Emanuelsson BM, Persson J, Sandin S, Alm C, Gustafsson LL. Intra-individual and interindividual variability in the disposition of the local anesthetic ropivacaine in healthy subjects. Ther Drug Monit 1997; 19: 126-131
18. Muir HA, Writer D, Douglas J, Weeks S, Gambling D, Macarthur A. Double-blind comparison of epidural ropivacaine 0.25% and bupivacaine 0.25%, for the relief of childbirth pain. Can J Anaesth 1997; 44: 599-604
19. McCrae AF, Westerling P, McClure JH. Pharmacokinetic and clinical study of ropivacaine and bupivacaine in women receiving extradural analgesia in labour. Br J Anaesth 1997; 79: 558-562